Annu Rev Immunol 2007, 25:21–50 PubMedCrossRef 8 Collin M, Olsén

Annu Rev Immunol 2007, 25:21–50.PubMedCrossRef 8. Collin M, Olsén A: Effect of SpeB and EndoS from Streptococcus pyogenes on human 4SC-202 concentration immunoglobulins. Infect Immun Fosbretabulin mw 2001,69(11):7187–7189.PubMedCrossRef 9. Tarentino AL, Plummer TH Jr: Enzymatic deglycosylation of asparagine-linked glycans: purification, properties, and specificity of oligosaccharide-cleaving enzymes from Flavobacterium meningosepticum . Methods Enzymol 1994, 230:44–57.PubMedCrossRef 10. Collin M, Svensson MD, Sjöholm AG, Jensenius JC, Sjöbring U, Olsén A: EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect Immun 2002,70(12):6646–6651.PubMedCrossRef 11. Allhorn

M, Olin AI, Nimmerjahn F, Collin M: Human IgG/Fc gamma R interactions are

modulated by streptococcal IgG glycan hydrolysis. PLoS One 2008,3(1):e1413.PubMedCrossRef 12. Collin M, Olsén A: Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes . Infection and Immunity 2003,71(6):2983–2992.PubMedCrossRef 13. Buchanan JT, Simpson AJ, Aziz RK, Liu GY, Kristian SA, Kotb M, Feramisco J, Nizet V: DNase find more expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr Biol 2006,16(4):396–400.PubMedCrossRef 14. Pence MA, Rooijakkers SH, Cogen AL, Cole JN, Hollands A, Gallo RL, Nizet V: Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus . J Innate Immun 2010. 15. Herwald H, Cramer H, Mörgelin M, Russell W, Sollenberg U, Norrby-Teglund A, Flodgaard H, Lindbom L, Björck L: M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 2004,116(3):367–379.PubMedCrossRef 16. Miyoshi-Akiyama T, Zhao J, Kikuchi K, Kato H, Suzuki R, Endoh M, Uchiyama T: Quantitative and qualitative comparison of

virulence traits, including murine lethality, among different M types of group A streptococci. J Infect Dis 2003,187(12):1876–1887.PubMedCrossRef to 17. Albert H, Collin M, Dudziak D, Ravetch JV, Nimmerjahn F: In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner. Proc Natl Acad Sci USA 2008,105(39):15005–15009.PubMedCrossRef 18. Aziz RK, Kotb M: Rise and persistence of global M1T1 clone of Streptococcus pyogenes . Emerg Infect Dis 2008,14(10):1511–1517.PubMedCrossRef 19. Sumby P, Barbian KD, Gardner DJ, Whitney AR, Welty DM, Long RD, Bailey JR, Parnell MJ, Hoe NP, Adams GG, et al.: Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc Natl Acad Sci USA 2005,102(5):1679–1684.PubMedCrossRef 20. Walker MJ, Hollands A, Sanderson-Smith ML, Cole JN, Kirk JK, Henningham A, McArthur JD, Dinkla K, Aziz RK, Kansal RG, et al.

Comments are closed.